• PT-141 (Bremelanotide) (90 Day)
PT-141 (Bremelanotide) (90 Day) - Image 1

PT-141 (Bremelanotide) (90 Day)

$599.99 every 3 months

A 90 day clinician-guided Bremelanotide program for eligible patients with persistent, distressing low sexual desire. The medication is used on demand and acts on brain pathways involved in desire rather than directly increasing genital blood flow.

Powered by Qualiphy

Add an on-demand treatment option for persistent low sexual desire after a clinician confirms the diagnosis.

Approved-use context: Branded bremelanotide is FDA-approved for patients with acquired, generalized hypoactive sexual desire disorder when the problem causes distress and is not better explained by another condition, medication, substance, or relationship issue.

What to expect: Nausea is common; flushing, headache, vomiting, and temporary blood-pressure increases can occur. The treatment is not appropriate for uncontrolled hypertension or known cardiovascular disease. Your clinician should confirm the exact product, dosing limits, and when to discontinue if symptoms do not improve.

Frequently bought together

Reviews

Be the first to review “PT-141 (Bremelanotide) (90 Day)”

Your email address will not be published. Required fields are marked *